Drug Channels Archive for October, 2016

Click a link below to view the mailing archive as if it had been sent to you.

2016-10-31 07:46Drug Channels - What McKesson’s Profit Warning Means for Manufacturers and Pharmacies
2016-10-28 07:34Drug Channels - Follow the Dollar: The Movie!
2016-10-27 07:36Drug Channels - Drug Channels News Roundup, October 2016: Gross-to-Net Bubble, Part D Rebates, EpiPen, and McKesson
2016-10-25 07:36Drug Channels - Walgreens Plays to Win: Our Exclusive Analysis of 2017's Part D Preferred Pharmacy Networks
2016-10-24 07:33Drug Channels - Real World Data for Competitive Advantage Summit
2016-10-20 08:12Drug Channels - The Top Specialty Drug Distributors in 2015
2016-10-18 07:08Drug Channels - Employer Pharmacy Benefits in 2016: More Specialty Drug Cost-Shifting Means More Problems for Patients
2016-10-17 07:40Drug Channels - ACO Operational Excellence
2016-10-14 07:42Drug Channels - Follow the Vial: The Buy-and-Bill System for Distribution and Reimbursement of Provider-Administered Outpatient Drugs
2016-10-13 07:35Drug Channels - Follow the Dollar: Measuring Who Profits From a Brand-Name Prescription
2016-10-11 07:37Drug Channels - Specialty Product Data Strategies
2016-10-06 07:50Drug Channels - Walgreens’ TRICARE Win: Tracking WBA’s Aggressive Preferred Network Deal Strategy
2016-10-05 07:41Drug Channels - EXCLUSIVE: Preferred Pharmacy Networks Are Back in 85% of the 2017 Medicare Part D Plans
2016-10-03 07:44Drug Channels - Life Sciences Trade and Channel Strategies 2016


<< Archive IndexSubscribe >>